CURTAILED SECRETABLE ASPARTYL-PROTEINASE 2 Russian patent published in 2013 - IPC C12N15/57 C12N9/60 C12N15/63 A61K38/48 

Abstract RU 2493255 C2

FIELD: biotechnologies.

SUBSTANCE: invention relates to a polypeptide of curtailed secretable aspartyl-proteinase 2, which is able to efficiently provoke antibody-mediated and cellular immune reactions at C.albicans and containing an amino acid sequence corresponding to SEQ ID NO:1; or a functionally equivalent polypeptide, which has an amino acid sequence produced from the SEQ ID NO:1 by means of one or more conservative substitutions of amino acids, besides, the specified polypeptide at least by 80% is identical to the amino acid sequence SEQ ID NO:1 for the entire length of SEQ ID NO:1. Also a polynucleotide is disclosed, which codes the specified polypeptide, an expression vector comprising the specified polynucleotide, a host cell for production of the specified polypeptide containing the specified vector. Compositions are disclosed for treatment or prevention of the infection Candida albicans, containing the specified polypeptide or polynucleotide in the efficient amount, and also the method for treatment and prevention of the infection Candida albicans using these compositions. Also a set is disclosed for diagnostics of the infection Candida albicans, containing the specified polypeptide and/or the specified polynucleotide and a reagent for detection of complexes that include the specified polypeptide.

EFFECT: invention makes it possible to efficiently provoke antibody-mediated and cellular immune reactions and has no disadvantages available in full-size aspartyl proteinase of wild type.

18 cl, 7 dwg, 1 tbl

Similar patents RU2493255C2

Title Year Author Number
COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS 2014
  • Ibrahim Ashraf S.
  • Yeaman Michael R.
  • Filler Scott G.
  • Edwards John E. Jr.
  • Hennessey John P. Jr.
RU2717306C2
VACCINE AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR TRIGGERING IMMUNE RESPONSE 2010
  • Long Debora
  • Flechtner Dzhessika
  • Skobern Mojka
  • Sajber Dzhorzh R.
RU2585961C9
NOVEL SOLUBLE POLYPEPTIDES CD83, COMPOSITIONS AND METHODS OF THEIR APPLICATION 2009
  • Brand Stefen
  • Chou Chikh-Khsiun
  • Moo-Joung Mjurrej
RU2535340C2
VERSIONS OF ERYTHROPOETINE 2006
  • Majzel' Andreas
  • Priller Jozef
  • Bonnas Kristel'
  • Dirnagl' Ul'Rikh
RU2430162C2
MULTI-COMPONENT IMMUNOGENIC COMPOSITION FOR PREVENTING DOSEASE, CAUSED BY β-HEMOLYTIC STREPTOCCOCI (BHS) 2009
  • Dodzh Ingrid Lia
  • Anderson Annaliesa Sibil
  • Khagen Majkl
  • Olmsted Stefan Brjus
RU2478396C2
MYCOBACTERIAL ANTIGEN COMPOSITION 2011
  • Kehrroll Majlz
  • Kholl Jper
  • Uill'Jams Ehnn
RU2576007C2
IpaD-PROTEIN SHIGELLA AND APPLYING IT AS SHIGELLA INFECTIONS VACCINE 2007
  • Alaui Adbel'Munaehm
  • Sansonetti Filippe
  • Sani Musa
  • Boto Anna
  • Parso Klod
  • Boekema Ehgbert Dzh.
RU2450826C2
STREPTOCOCCUS PNEUMONIAE VACCINES AND COMPOSITIONS 2010
  • Giran Todd
  • Melli Richard
RU2580299C2
HOST CELLS AND WAYS TO USE 2014
  • Tszin Yunkhvan
  • Chzhu Yuan
RU2663587C2
NEUROTOXINS SHOWING SHORTENED BIOLOGICAL ACTIVITY 2012
  • Shmidt Mikhael
  • Frevert Yurgen
  • Khofmann Fred
  • Groer Gerkhard
RU2646110C2

RU 2 493 255 C2

Authors

Tsurbriggen Rinal'Do

De Bernardis Flavija

Kassone Antonio

Rasi Sil'Vija

Dates

2013-09-20Published

2008-09-19Filed